Cannenta develops wound dresings using patented 2-deoxy-D-ribose (2dDR) technology to accelerate healing by promoting blood vessel growth. This reduces complications, speeds recovery, and eases the burden on healthcare systems.
Archives: Startups
ChezLeon
ChezLeon designs & manufactures wearable inserts to manage fluid blockages, through passive massage. Our initial patented design, a Bra Insert for early intervention, relieving pain & swelling in the treatment & prevention of lymphoedema following Breast Cancer. The Insert fits discretely inside a Bra helping patients regain their freedom & quality of life.
Anto Medcare
We are building a product based on the combination of proprietary sensor-based smart pad and algorithm that can predict and prevent the pressure injury and falling risks for wheelchair users.
ONWARD Health Research
We are a Singapore-based clinical research technology and services company aimed at improving participant and healthcare provider access to clinical research while lowering costs via ONWARDAccess, our proprietary cloud-based clinical research platform.
SOTERIUS
Soterius is an Australian startup that is developing solutions for respiratory diseases. We have developed a wearable sensor capable of detecting COVID19 in the environment with high degrees of accuracy and sensitivity. This sensor provides information via a mobile phone application on if users have been exposed to the virus as they go about their daily activities.
Data Dissect
Enabling simple and cost-effective collection, analysis, and interpretation of clinical data.
Connect2MyDoctor
Comprehensive virtual care platform to complement how people access and experience healthcare around the world.
Pronto Bottle
The world’s first self-sanitising baby bottle allowing parents to travel faster and lighter with a bottle fed baby.
Nirtek
Coronary intravascular imaging to reduce hospital re-admission after Percutaneous Coronary Intervention.
Neuromersiv
Neuromersiv empowers stroke, spinal cord and acquired brain injury survivors by helping them regain this lost independence and quality of life. This is achieved by enhancing rehabilitation to maximise engagement and compliance. By utilising multiple sensory inputs, Neuromersiv’s “Ulysses” VR-based upper limb therapy system has the potential to promote faster recovery.
